Seaflower Ventures
Overview
Seaflower Ventures is a venture capital firm specializing in early-stage life sciences investments. The firm focuses on supporting innovation in medical technologies and healthcare solutions. Their investment strategy encompasses a wide range of industries, including biotechnology, business and consumer products, computer hardware, financial services, healthcare, IT services, industrial and energy products, media and entertainment, medical equipment, networking, retailing and distribution, semiconductors, software, telecommunications, and real estate. Seaflower Ventures has a history of supporting companies in various stages of development, from seed funding to pre-IPO and buyout acquisitions. Their portfolio includes companies such as Targanta Therapeutics, a biopharmaceutical company developing antibacterial drugs for serious hospital infections.
Investment Focus
- Private Company (backed by venture capital firms)
- Private Company (not backed by venture capital firms)
- Public Company
Portfolio Companies
Reach Seaflower Ventures directly
Verified work email, phone and LinkedIn for the full team — one spreadsheet, one payment, yours to keep.
Unlock full contacts →Frequently asked questions about Seaflower Ventures
What sectors does Seaflower Ventures invest in?
Seaflower Ventures invests in Financial Services, Healthcare, Real Estate, Telecommunications, Software and Semiconductors, and is based in Massachusetts, United States. Seaflower Ventures is listed as a venture capital in the ConnectSafely investor database.
What stage does Seaflower Ventures invest at?
Seaflower Ventures backs companies at Seed and Pre-IPO.
Which regions does Seaflower Ventures invest in?
Seaflower Ventures invests across United States.
What companies has Seaflower Ventures invested in?
Seaflower Ventures's portfolio includes Targanta Therapeutics.
Last updated · Source: ConnectSafely investor database
